Newest Coated Stent Does Well in Real-World Trial

The newest drug-coated stent has performed well in a real-life trial, Dutch cardiologists report.

The Xience stent — a flexible metal-mesh tube coated with the drug everolimus — is inserted to keep blood flowing after artery-opening procedures such as angioplasty, and is already in widespread use. It was approved by the U.S. Food and Drug Administration last July, on the basis of good results in controlled trials.

More at Health.com